-
Trump renames AI "super intelligence," rejects international oversight
-
Moldova declares energy, water emergency
-
Trump rejects international regulation of AI
-
French Holocaust denier jailed for eight months
-
How is the EU approaching record fuel prices?
-
Oil prices slide, AI stock buzz fades
-
Sri Lanka's Colombage strikes on debut as England dismissed for 265 in first ODI
-
Trump threatens to 'annihilate' Iran in bombastic UN speech
-
Hurricane Polo strengthens to top category 5 off Mexico
-
Prada's skirts take centre stage as Milan Fashion Week begins
-
11 hurt as teen opens fire outside school in western Turkey
-
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
-
UN chief says 'Big Oil' treats atmosphere as open sewer
-
Brazil's Flavio Bolsonaro turns scandal into poll gains
-
Tunisia says 2026 summer hottest on record
-
Republican senator seeks probe of Trump Jr Russian-funded wedding
-
England's Rashid out of Sri Lanka ODIs with hand injury
-
Memoir by Diana's brother goes on sale after rocking UK monarchy
-
Houthis accuse Saudi Arabia of deadly strikes as thousands flee
-
Newcomers South Korea face holders Italy in Davis Cup finals
-
Stocks climb as oil slides, AI buzz returns
-
Japan's Kojima sounds Marchand warning with Asian Games gold
-
India cricketers win in style as Afghan savours 'special' Games silver
-
England rugby star Pollock signs new Northampton deal
-
La Liga president hits out at Real Madrid refereeing 'conspiracy' claims
-
STARTRADER Expands Its Chinese Equity CFD Range with CXMT and Unitree Robotics
-
MEXC Launches “Real Stocks, Real Friends” with Rewards for Bringing Friends to Wall Street
-
MEXC Expands Opportunity Compass with Stock Trading Handbook to Help Crypto Users Build Investment Knowledge
-
Mbappe continues media push for Ballon d'Or recognition
-
England paceman Wood retires from international cricket
-
Stocks rise on AI buzz, oil prices cool
-
Magnificent Mandhana's 79 helps India to Asian Games cricket gold
-
India narrowly survive huge scare against minnows Japan
-
Marchand 'stressed' about racing Japanese rivals at LA Olympics
-
Missing F-35 fighter parts 'not sensitive', says Australia minister
-
Mobile boat clinics bring healthcare to India's remote islands
-
Cambodia showcases scams crackdown with global conference
-
Former India paceman Zaheer Khan named Chennai coach in IPL
-
Afghan cyclist who disguised herself as man wins Asian Games silver
-
Six-year-old Chinese girl sets world record with Rubik's Cube
-
Typhoon Dujuan leaves four dead in Japan, 45,000 houses without power
-
Swimming prodigy Yu, 13, says 'interviews way harder than racing'
-
G7 leaders condemn Houthi strikes on Saudi Arabia
-
Star coaches make their bows as Nations League returns
-
Google data centre sparks protests in Austria
-
Rams bounce back as Giants reel from Dart injury
-
Shin Ohashi: Junk food-loving teen and Japan's next big swimming hope
-
In Bangladesh, Pakistan's Jinnah photo stirs anger
-
Stocks rise on AI buzz, drop in oil prices
-
Two New Zealand naval ships transit Taiwan Strait
Brazil's banana spider aids erectile dysfunction treatment
Three decades ago, Brazilian researchers began studying a curious side effect from banana spider bites: the toxin left victims with priapism, a painful and persistent erection.
The scientists were inspired to develop a synthetic molecule using some properties of the spider's poison to create a gel to treat erectile dysfunction, which is now undergoing promising clinical trials.
Covered in thick brown hair, and with a maximum size of up to 15 centimeters (six inches), the arachnid is one of the most poisonous in the world.
It is found in several South American countries, and was nicknamed for its common presence in banana plantations, but it is also called the "wandering spider" or "armed spider."
In the southeastern Brazilian state of Minas Gerais, it is found in rural areas as well as urban centers.
At the Ezequiel Dias Foundation (FUNED), a medical research center in the state's capital Belo Horizonte, a biologist delicately grabs one of the spiders with a pair of tweezers and stimulates its fangs to get a few drops of venom.
FUNED then sends the venom to the Federal University of Minas Gerais (UFMG) which has been researching which component could be replicated to treat erectile dysfunction, which affects tens of millions of men around the world.
"The venom is only used to learn the properties of the molecule" which causes the priapism in bite victims, said Maria Elena de Lima, a UFMG researcher.
Brazilian biotech company Biozeus has bought the patent for the molecule.
The company wants to sell it in an ointment, which would be rubbed on the penis when required, resulting in an erection in a few minutes, said de Lima.
The molecule triggers the release of nitric oxide, which is essential for an erection as it increases blood circulation and allows blood vessels to widen.
De Lima said the research could be especially useful in the fight against cancer, as men suffering prostate cancer often refuse a procedure to remove the prostate because it can damage nerves and lead to erectile dysfunction.
After the first phase of clinical trials was approved by Brazil's Anvisa regulatory agency, the medication has now moved into the second of three phases prior to being approved for sale.
De Lima said the discovery of a potential erectile dysfunction treatment was a message "not to destroy animals, even poisonous ones, because there is a real library of molecules that are still unknown."
S.Spengler--VB